179 related articles for article (PubMed ID: 9559679)
21. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
22. Formation of reactive intermediates from Amadori compounds under physiological conditions.
Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
[TBL] [Abstract][Full Text] [Related]
23. Sunlight induces N epsilon-(carboxymethyl)lysine formation from glycated polylysine-iron(III) complex.
Sakurai T; Fujimori K; Ueda T; Shindo H; Shibusawa Y; Nakano M
Photochem Photobiol; 2001 Sep; 74(3):407-11. PubMed ID: 11594053
[TBL] [Abstract][Full Text] [Related]
24. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
[TBL] [Abstract][Full Text] [Related]
25. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
Berg TJ; Clausen JT; Torjesen PA; Dahl-Jørgensen K; Bangstad HJ; Hanssen KF
Diabetes Care; 1998 Nov; 21(11):1997-2002. PubMed ID: 9802757
[TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.
Schram MT; Schalkwijk CG; Bootsma AH; Fuller JH; Chaturvedi N; Stehouwer CD;
Hypertension; 2005 Jul; 46(1):232-7. PubMed ID: 15851628
[TBL] [Abstract][Full Text] [Related]
27. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Choi YG; Lim S
J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
[TBL] [Abstract][Full Text] [Related]
28. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation of ascorbic acid promotes the reduction of Maillard reaction products in UHT milk.
Troise AD; Vitiello D; Tsang C; Fiore A
Food Funct; 2016 Jun; 7(6):2591-602. PubMed ID: 27240727
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunoassay of glycosylated albumin with monoclonal antibody to glucitol-lysine.
Ohe Y; Matsuura M; Nakajima Y; Shin S; Hashimoto F; Hirota M; Shima K
Clin Chim Acta; 1987 Nov; 169(2-3):229-38. PubMed ID: 3123099
[TBL] [Abstract][Full Text] [Related]
31. Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle.
Masania J; Wijten P; Keipert S; Ost M; Klaus S; Rabbani N; Thornalley PJ
Redox Biol; 2023 Feb; 59():102574. PubMed ID: 36521306
[TBL] [Abstract][Full Text] [Related]
32. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
[TBL] [Abstract][Full Text] [Related]
33. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
[TBL] [Abstract][Full Text] [Related]
34. Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.
Nagai R; Unno Y; Hayashi MC; Masuda S; Hayase F; Kinae N; Horiuchi S
Diabetes; 2002 Sep; 51(9):2833-9. PubMed ID: 12196478
[TBL] [Abstract][Full Text] [Related]
35. Suppression of N(epsilon)-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine.
Nakayama M; Izumi G; Nemoto Y; Shibata K; Hasegawa T; Numata M; Wang K; Kawaguchi Y; Hosoya T
Perit Dial Int; 1999; 19(3):207-10. PubMed ID: 10433156
[TBL] [Abstract][Full Text] [Related]
36. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of aged rat.
Kobayashi S; Nomura M; Nishioka T; Kikuchi M; Ishihara A; Nagai R; Hagino N
Biol Pharm Bull; 2007 Jan; 30(1):133-8. PubMed ID: 17202673
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
38. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.
Takeuchi M; Makita Z; Yanagisawa K; Kameda Y; Koike T
Mol Med; 1999 Jun; 5(6):393-405. PubMed ID: 10415164
[TBL] [Abstract][Full Text] [Related]
39. Formation and inhibition of Nε-(carboxymethyl)lysine in saccharide-lysine model systems during microwave heating.
Li L; Han L; Fu Q; Li Y; Liang Z; Su J; Li B
Molecules; 2012 Oct; 17(11):12758-70. PubMed ID: 23114613
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
